Earnings (Loss) per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 27, 2020	Sep. 27, 2020	Jun. 28, 2020	Mar. 29, 2020	Dec. 29, 2019	Sep. 29, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 27, 2020	Dec. 29, 2019	Dec. 30, 2018
Basic (loss) earnings per common share:
Net income (loss) attributable to the Company	$ 13,167	$ 15,708	$ 20,614	$ 8,443	$ (2,142)	$ 385	$ 8,354	$ (1,731)	$ 57,932	$ 4,866	$ 2,474
Dividends paid to participating securities and accretion									(14,059)	(12,499)
Net income attributable to participating securities									(2,136)
Net income (loss) attributable to common shareholders									$ 41,737	$ (7,633)	$ 2,474
Basic weighted average common shares outstanding									32,421,000	31,632,000	32,083,000
Basic earnings (loss) per common share	$ 0.29	$ 0.35	$ 0.49	$ 0.15	$ (0.18)	$ (0.10)	$ 0.15	$ (0.12)	$ 1.29	$ (0.24)	$ 0.08
Diluted (loss) earnings per common share:
Net income (loss) attributable to common shareholders									$ 41,737	$ (7,633)	$ 2,474
Basic weighted average common shares outstanding									32,421,000	31,632,000	32,083,000
Dilutive effect of outstanding equity awards									296,000		216,000
Diluted weighted average common shares outstanding									32,717,000	31,632,000	32,299,000
Diluted earnings (loss) per common share	$ 0.28	$ 0.35	$ 0.48	$ 0.15	$ (0.18)	$ (0.10)	$ 0.15	$ (0.12)	$ 1.28	$ (0.24)	$ 0.08
Weighted average antidilutive awards excluded from computation of earnings per share									100,000	0	1,200,000
Joint ventures
Basic (loss) earnings per common share:
Net income (loss) attributable to the Company									$ 8,336	$ 3,351	$ 7,393
Series B Preferred Stock
Diluted (loss) earnings per common share:
Weighted average antidilutive awards excluded from computation of earnings per share									252,500,000	252,500,000
Weighted average antidilutive awards if converted									5,000,000.0	5,000,000.0